A small case-controlled human trial of SFA002
Latest Information Update: 13 Jul 2020
Price :
$35 *
At a glance
- Drugs SFA 002 (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors SFA Therapeutics
- 13 Jul 2020 New trial record
- 29 Jun 2020 Results published in the SFA Therapeutics Media Release.